Brevan Howard Capital Management LP Insulet Corp Transaction History

Brevan Howard Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$161.02 - $206.98 $111,586 - $143,437	-693 Reduced 21.2%	2,576 $519,000
Q1 2024 May 15, 2024	SELL	$163.6 - $209.11 $216,442 - $276,652	-1,323 Reduced 28.81%	3,269 $560,000
Q4 2023 Feb 14, 2024	BUY	$127.77 - $221.42 $586,719 - $1.02 Million	4,592 New	4,592 $996,000

696

62.6M

640K

841K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Brevan Howard Capital Management LP with notifications on news.